PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
32304024-0	2020	A Population Pharmacokinetics Model for Vancomycin Dosage Optimization Based on Serum Cystatin C.	Vancomycin	40-50	cystatin C	Homo sapiens	86-96	
32304024-1	2020	BACKGROUND AND OBJECTIVES: Renal function has an important influence on the pharmacokinetics of vancomycin, and serum cystatin C (CysC) exhibits accurate predictive performance as a marker for renal function.	Vancomycin	96-106	cystatin C	Homo sapiens	118-128	
32304024-1	2020	BACKGROUND AND OBJECTIVES: Renal function has an important influence on the pharmacokinetics of vancomycin, and serum cystatin C (CysC) exhibits accurate predictive performance as a marker for renal function.	Vancomycin	96-106	cystatin C	Homo sapiens	130-134	
32304024-2	2020	This study aimed to develop a population pharmacokinetics (PopPK) model of vancomycin based on serum CysC in pediatric patients.	Vancomycin	75-85	cystatin C	Homo sapiens	101-105	
32304024-7	2020	Serum CysC and age were significant covariates affecting the pharmacokinetics of vancomycin.	Vancomycin	81-91	cystatin C	Homo sapiens	6-10	
32304024-10	2020	CONCLUSIONS: The pharmacokinetic parameters for vancomycin in pediatric patients were estimated using a serum CysC model.	Vancomycin	48-58	cystatin C	Homo sapiens	110-114